Back to All News

Newsweek Highlights Whole Genome Sequencing Work at Washington University

|
Duncavage V2

Pioneering work in genetic testing at Washington University School of Medicine and elsewhere has yielded invaluable – even lifesaving – information for cancer patients and physicians. Newsweek spotlights these groundbreaking advances, including WashU’s sequencing of the first cancer genome, as well as the development of ChromoSeq, the only whole genome sequencing test approved by Medicare, by Washington University pathologist Eric Duncavage, MD, at Siteman Cancer Center.

Read the article.

Learn more about ChromoSeq: